Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Clinical trial NCT02168829 · COMPLETED
Trial details
- NCT number
- NCT02168829
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2025-08-14
- Enrollment
- 1284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.